Article · 29 Aug 2026
Conference abstract
The effect of new leishmania vaccine against Th1, Th2 as well as increasing of spleen white pulp size in Balb /c mice after repeated exposure
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Introduction: Human leishmaniasis is distributed worldwide, but mainly in the tropics and subtropics, with a prevalence of 12 million cases and an approximately incidence of 0.5 million cases of VL and 1.5 million cases of cutaneous leishmaniasis (CL). Leishmania parasites are vector-born protozoan pathogens found in tropical and subtropical regions of both the old and new world. The disease in human can be divided into cutaneous, visceral, and mucosal syndromes. The aim of this study was more experiments over our previous new formulation modify leishmania major antigen that had satisfactory results, before. Material and Method: In this study we have made preliminarily new vaccine with the same methodology again and selected two injection doses (100 & 200 μg/0.1ml), three injection groups: Leishmania plus BCG (LB), Leishmania plus new adjuvant (Teucrium Polium)[LT], leishmania plus BCG and Teucrium Polium (LBT), and one susceptible mice(Balb/c) and measure two type cytokines:Th1(IFN- γ, IL-12)and Th2(IL-4, IL-10) and expansion of white pulp size after challenge with live leishmania. Results: Results show that both doses over LBT group have highest IL-12, lowest IL-10 and highest increasing in spleen?s white pulp size, whether; other groups have lower IL-12, higher IL-10 and lowest increased size in spleen?s white pulp in susceptible mice. Correlation to IL-12 and Il-10, IFN- γ and IL-4 against to spleen?s white pulp expansion is significant Conclusion: Our study show that in Balb/c mice, best injection group that produced highest IL-12 and lowest IL-10 which have significant differences, is LBT group, and adjuvants BCG both Teucrium which have synergic effect with together. And also, higher spleen?s white pulp size increasing was seen in LBT group PDF HTML
Keywords
Subjects
Vaccines & ImmunisationAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Journal of Vaccines & Vaccination.
Article · 29 Aug 2026
Advances in Adjuvant Development for Enhanced Vaccine Performance and Long-Term Immune Protection
Article · 20 Jun 2026
Herd Immunity and Its Role in Controlling Infectious Diseases
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Vaccines & Vaccination
- SubjectVaccines & Immunisation
- BylineArticles whose byline prints “Latifynia Afshineh”
- BylineArticles whose byline prints “Hajaran H”
- BylineArticles whose byline prints “Mir Amin Mohammady”
- BylineArticles whose byline prints “Gheflati Z”
- BylineArticles whose byline prints “N Khansari”